Maraj Suraj, Jacobs Larry E, Maraj Rajiv, Contreras Rafael, Rerkpattanapipat Pairoj, Malik Taseem A, Manzarbeitia Cosme, Munoz Santiago, Rothstein Kenneth, Kotler Morris N
Echocardiography Laboratory, Division of Cardiology, Albert Einstein Medical Center, Philadelphia, Pennsylvania 19141, USA.
Echocardiography. 2004 Nov;21(8):681-5. doi: 10.1111/j.0742-2822.2004.03068.x.
Dobutamine stress echocardiography (DSE) is frequently used in the evaluation of cardiac risk prior to orthotopic liver transplantation (OLT). In the general cardiac population, an inducible left ventricular outflow tract gradient (LVOT Delta) during DSE has variable prognostic importance. The purpose of this study was to determine the prevalence and clinical significance of LVOT Delta in patients undergoing OLT during DSE.
Consecutive medical records of 106 patients who had undergone OLT at our institution from January 1997 until January 2002 were retrospectively analyzed and divided into two groups based on the presence (Group I, LVOT Delta >36 mmHg) or absence (Group II, LVOT Delta< or = 36 mmHg) of a significant LVOT Delta measured during DSE. We determined any outcome differences between these two groups with regard to intraoperative hypotension, cardiac mortality, length of hospital stay, graft function, and renal function post-OLT.
Forty-six patients had an LVOT Delta > 36 mmHg (Group I) and 60 patients had LVOT Delta< or = 36 mmHg (Group II). Baseline demographics were similar in both groups. There was no significant overall difference in cardiac mortality between Group I versus Group II patients (0 versus 1 patient, respectively, P=0.57). Intraoperative hypotension occurred in 4 patients in Group I versus 0 patient in Group II (P=0.03). Length of stay, graft function, and postoperative renal function were similar in both groups.
A significant LVOT Delta >36 mmHg is a frequent finding occurring in 46/106 (43%) of patients who have DSE pre-OLT. Intraoperative hypotension is associated with patients having an LVOT Delta. However, post-OLT patients with significant LVOT Delta have a similar in-hospital outcome compared to patients without significant LVOT Delta.
多巴酚丁胺负荷超声心动图(DSE)常用于原位肝移植(OLT)术前心脏风险评估。在一般心脏人群中,DSE期间诱导性左心室流出道压差(LVOT Δ)具有不同的预后意义。本研究的目的是确定OLT患者在DSE期间LVOT Δ的发生率及临床意义。
回顾性分析1997年1月至2002年1月在我院接受OLT的106例患者的连续病历,并根据DSE期间测量的显著LVOT Δ的存在情况(I组,LVOT Δ>36 mmHg)或不存在情况(II组,LVOT Δ≤36 mmHg)分为两组。我们确定了这两组在术中低血压、心脏死亡率、住院时间、移植肝功能和OLT术后肾功能方面的任何结果差异。
46例患者LVOT Δ>36 mmHg(I组),60例患者LVOT Δ≤36 mmHg(II组)。两组的基线人口统计学特征相似。I组和II组患者的心脏死亡率无显著总体差异(分别为0例和1例患者,P = 0.57)。I组4例患者发生术中低血压,II组0例患者发生术中低血压(P = 0.03)。两组的住院时间、移植肝功能和术后肾功能相似。
显著LVOT Δ>36 mmHg在46/106(43%)的OLT术前进行DSE的患者中很常见。术中低血压与LVOT Δ的患者相关。然而,与无显著LVOT Δ的患者相比,OLT术后有显著LVOT Δ的患者院内结局相似。